Study of Chemotherapy Side Effects in Cancer Patients: Non-invasive Optical Measurements of the Brain
18 Years
70 Years
Both
Effects of Chemotherapy
Trial Information
Study of Chemotherapy Side Effects in Cancer Patients: Non-invasive Optical Measurements of the Brain
The researcher study about the integration of NIDOI and psychometric testing with initiation
of active cytotoxic chemotherapeutic treatment.
The researcher study about the feasibility of NIDOI analysis in patients undergoing initial
cytotoxic chemotherapy for cancer and to explore associations in these optical parameters
between patient reported outcomes reflective of disruption of quality of life (QOL) and
chemobrain-mild cognitive impairment and to test the research hypothesis is that among
cancer patients, those who develop chemobrain symptoms will experience a greater mean
reduction in brain tissue oxygen saturation than those who do not.
Inclusion Criteria:
- have a histologically proven cancer.
- Planned initiation of chemotherapy
- age range between 18-70 years
Exclusion Criteria:
- have NO a histologically proven cancer.
- NO planned chemotherapy
- age less than 18 years
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
monitoring chemotherapy side effects
Outcome Description:
symptoms associated with the chemobrain syndrome
Outcome Time Frame:
6 months
Safety Issue:
No
Principal Investigator
Edward Nelson, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Beckman Laser Institute University of California Irvine
Authority:
United States: Institutional Review Board
Study ID:
LAMMP-30139; HS#2008-6549
NCT ID:
NCT01277276
Start Date:
November 2008
Completion Date:
November 2015
Related Keywords:
- Effects of Chemotherapy
- chemobrain
Name | Location |
|---|---|
| Beckman Laser Institute Medical clinic | Irvine, California 92612 |
